International Clinical Trials Day on 20 May: why James Lind still matters today

Every year on 20 May, we mark International Clinicals Trial Day. On this day, we reflect on the importance of clinical research and on the people who contribute to it. The date refers to the work of James Lind, a Scottish naval surgeon who took an important step in the history of clinical studies in 1747.

His research into scurvy is often regarded as one of the first controlled clinical trials. It helped lay the foundation for the way we investigate new treatments today in a scientific and safe manner.

Who was James Lind?

James Lind was a doctor in the British Navy. In the eighteenth century, scurvy was a serious problem among sailors. During long sea voyages, many crew members suffered from fatigue, bleeding gums, weak muscles and wounds that healed poorly. In severe cases, the disease could be fatal.

Today, we know that scurvy is caused by a lack of vitamin C. In James Lind’s time, this was not yet known. Various treatments existed, but nobody knew for certain which approach actually worked.

That is why Lind decided to compare the treatments.

The study in 1747

On 20 May 1747, James Lind selected twelve sailors with scurvy on board HMS Salisbury. He divided them into six small groups. All sailors received the same basic diet, but each group was given a different treatment in addition.

One of the groups received citrus fruits, such as oranges and lemons. That group recovered noticeably faster than the other groups.

For that time, this was an innovative approach. Lind did not rely only on individual experiences or opinions, but compared different treatments in a structured way. That principle remains central to clinical research today.

Why is James Lind important for clinical research?

James Lind’s study was small and simple compared with modern clinical studies. Even so, his approach was important because he showed that medical decisions become stronger when they are based on comparison, observation and data.

That is still the core of clinical research today. Researchers want to know whether a treatment is safe, how well it works and for whom it may be suitable.

Modern clinical studies are, of course, conducted much more strictly than in Lind’s time. Every study is reviewed in advance. Participant safety is carefully monitored. Participants receive clear information and decide voluntarily whether they want to take part.

International Clinical Trials Day: a day for science and participants

International Clinical Trials Day reminds us that medical progress begins with research. From James Lind in 1747 to the clinical studies of today, reliable medical knowledge is built through careful research and the commitment of pioneers.

That is why, on 20 May, we thank everyone who makes clinical research possible!